These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 32833672)

  • 1. SNAI1 is a prognostic biomarker and correlated with immune infiltrates in gastrointestinal cancers.
    Fang J; Ding Z
    Aging (Albany NY); 2020 Aug; 12(17):17167-17208. PubMed ID: 32833672
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LAYN Is a Prognostic Biomarker and Correlated With Immune Infiltrates in Gastric and Colon Cancers.
    Pan JH; Zhou H; Cooper L; Huang JL; Zhu SB; Zhao XX; Ding H; Pan YL; Rong L
    Front Immunol; 2019; 10():6. PubMed ID: 30761122
    [No Abstract]   [Full Text] [Related]  

  • 3. High expression of MYEOV reflects poor prognosis in non-small cell lung cancer.
    Zhang R; Ma A
    Gene; 2021 Feb; 770():145337. PubMed ID: 33278551
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comprehensive Analysis of the Expression, Relationship to Immune Infiltration and Prognosis of TIM-1 in Cancer.
    Kong X; Fu M; Niu X; Jiang H
    Front Oncol; 2020; 10():1086. PubMed ID: 33014768
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The expression and clinical significance of an Epithelial-Mesenchymal Transition inducer, SNAI1, in head and neck carcinoma.
    Zhao H; Ling J; Huang Y; Chang A; Zhuo X
    J Oral Pathol Med; 2021 Feb; 50(2):145-154. PubMed ID: 32945534
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Upregulation of Synuclein-
    Yang J; Pan Y; Peng L; Zhang L; Zhao J; Zheng Z; Zheng J; Xu X; Zeng Y
    Biomed Res Int; 2022; 2022():6534626. PubMed ID: 35434126
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel ESCC-related gene ZNF750 as potential Prognostic biomarker and inhibits Epithelial-Mesenchymal Transition through directly depressing SNAI1 promoter in ESCC.
    Kong P; Xu E; Bi Y; Xu X; Liu X; Song B; Zhang L; Cheng C; Yan T; Qian Y; Yang J; Ma Y; Cui H; Zhai Y; Zou B; Liu X; Cheng Y; Guo S; Cheng X; Cui Y
    Theranostics; 2020; 10(4):1798-1813. PubMed ID: 32042337
    [No Abstract]   [Full Text] [Related]  

  • 8. Prognostic value of epithelial-mesenchymal transition markers in clear cell renal cell carcinoma.
    Xu H; Xu WH; Ren F; Wang J; Wang HK; Cao DL; Shi GH; Qu YY; Zhang HL; Ye DW
    Aging (Albany NY); 2020 Jan; 12(1):866-883. PubMed ID: 31915310
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic Prediction, Immune Microenvironment, and Drug Resistance Value of Collagen Type I Alpha 1 Chain: From Gastrointestinal Cancers to Pan-Cancer Analysis.
    Liu Y; Xue J; Zhong M; Wang Z; Li J; Zhu Y
    Front Mol Biosci; 2021; 8():692120. PubMed ID: 34395525
    [No Abstract]   [Full Text] [Related]  

  • 10. FoxM1 overexpression promotes epithelial-mesenchymal transition and metastasis of hepatocellular carcinoma.
    Meng FD; Wei JC; Qu K; Wang ZX; Wu QF; Tai MH; Liu HC; Zhang RY; Liu C
    World J Gastroenterol; 2015 Jan; 21(1):196-213. PubMed ID: 25574092
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Visfatin facilitates gastric cancer malignancy by targeting snai1 via the NF-κB signaling.
    Cao D; Chu L; Xu Z; Gong J; Deng R; Wang B; Zhou S
    Hum Exp Toxicol; 2021 Oct; 40(10):1646-1655. PubMed ID: 33823623
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA-153 acts as a prognostic marker in gastric cancer and its role in cell migration and invasion.
    Zhang Z; Sun J; Bai Z; Li H; He S; Chen R; Che X
    Onco Targets Ther; 2015; 8():357-64. PubMed ID: 25678802
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ionizing Radiation Promotes Epithelial-Mesenchymal Transition Phenotype and Stem Cell Marker in The Lung adenocarcinoma: In Vitro and Bioinformatic Studiesc.
    Raei M; Bagheri M; Aghaabdollahian S; Ghorbani M; Sadeghi A
    Cell J; 2022 Sep; 24(9):522-530. PubMed ID: 36274205
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Follistatin-like 1 (FSTL1) is a prognostic biomarker and correlated with immune cell infiltration in gastric cancer.
    Li L; Huang S; Yao Y; Chen J; Li J; Xiang X; Deng J; Xiong J
    World J Surg Oncol; 2020 Dec; 18(1):324. PubMed ID: 33292276
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CFP is a prognostic biomarker and correlated with immune infiltrates in Gastric Cancer and Lung Cancer.
    Cui G; Geng L; Zhu L; Lin Z; Liu X; Miao Z; Jiang J; Feng X; Wei F
    J Cancer; 2021; 12(11):3378-3390. PubMed ID: 33976747
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comprehensive Pan-Cancer Genomic Analysis Reveals PHF19 as a Carcinogenic Indicator Related to Immune Infiltration and Prognosis of Hepatocellular Carcinoma.
    Zhu ZY; Tang N; Wang MF; Zhou JC; Wang JL; Ren HZ; Shi XL
    Front Immunol; 2021; 12():781087. PubMed ID: 35069553
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ITGA5 is a prognostic biomarker and correlated with immune infiltration in gastrointestinal tumors.
    Zhu H; Wang G; Zhu H; Xu A
    BMC Cancer; 2021 Mar; 21(1):269. PubMed ID: 33711961
    [TBL] [Abstract][Full Text] [Related]  

  • 18. miR-30b-5p modulate renal epithelial-mesenchymal transition in diabetic nephropathy by directly targeting SNAI1.
    Wang Y; Liu Y; Zhang L; Bai L; Chen S; Wu H; Sun L; Wang X
    Biochem Biophys Res Commun; 2021 Jan; 535():12-18. PubMed ID: 33383483
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immune Infiltration-Related Signature Predicts Risk Stratification and Immunotherapy Efficacy in Grade II and III Gliomas.
    Luo C; Liu Z; Ye W; Liu F
    Front Cell Dev Biol; 2021; 9():756005. PubMed ID: 34805164
    [No Abstract]   [Full Text] [Related]  

  • 20. A novel tumor mutational burden-based risk model predicts prognosis and correlates with immune infiltration in ovarian cancer.
    Wang H; Liu J; Yang J; Wang Z; Zhang Z; Peng J; Wang Y; Hong L
    Front Immunol; 2022; 13():943389. PubMed ID: 36003381
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.